[Suppression of cignolin-induced erythema by tar].
D000873:Anthracenes / Q000009:adverse effects* / Q000627:therapeutic use*; D000875:Anthralin / Q000009:adverse effects* / Q000627:therapeutic use*; D003033:Coal Tar / Q000009:adverse effects / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations / Q000009:adverse effects / Q000627:therapeutic use; D004890:Erythema / Q000139:chemically induced*; D006801:Humans; D008297:Male; D010577:Petrolatum / Q000009:adverse effects / Q000627:therapeutic use*; D011565:Psoriasis / Q000188:drug therapy*; D012459:Salicylates / Q000009:adverse effects / Q000627:therapeutic use*
D000873:Anthracenes; D003879:Dermatologic Agents; D004338:Drug Combinations; D012459:Salicylates; C041563:TCVS; D003033:Coal Tar; D010577:Petrolatum; D000875:Anthralin
Unterdrückung des Cignolin-bedingten Erythems durch Teer.